L2P RESEARCH
Live / Registered — Registered (as of 13 Dec 2022)
What this means for you
Registered since 13 Dec 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88984763
- Registration number
- 6925449
- Mark type
- Stylized text
- Filed
- 02 Jan 2020
- Published for opposition
- 12 May 2020
- Registered
- 13 Dec 2022
- Attorney of record
- James F. Harrington
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; Research and development of advanced learning technologies and teaching methods; Research and development of new products; Research and development of new products for others; Research and development of vaccines and medicines; Research and development services in connection with physics; Research and development services in the field of antibodies; Research in the area of semiconductor processing technology; Research in the field of chemistry; Research on the subject of pharmaceuticals; Agrochemical research services; Bacteriological research; Bacteriological consultation and research; Biochemical research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical research; Conducting clinical trials for others; Consulting services in the field of hydrological research; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Genotyping services for research or analysis purposes; Industrial research in the field of Biotechnology; Industrial research in the field of Immunology; Integrated scientific research on vermin for greenhouses and harvest crops; Laboratory research services relating to pharmaceuticals; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of Oncology; Medical and scientific research in the field of Cancer; Medical and scientific research in the field of Nature Therapeutics; Pharmaceutical research and development; Pharmaceutical research services; Product research; Product research and development; Providing information in the field of plant genetics research resources; Providing medical research and scientific research information in the field of oncology via the Internet; Providing scientific research information in the field of Tumor Immunology; Providing scientific research information in the field of Pre clinical Research; Providing scientific research information in the field of Animal Research; Scientific research; Scientific research and development; Scientific research consulting in the field of cosmetics; Scientific research consulting in the field of in vitro fertilization; Scientific research for medical purposes in the area of cancerous diseases; Scientific and technological research relating to patent mapping; Technical research in the field of pharmaceutical studies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Zoological research and consultation
Owner
- Lab TO Pharmacy, LLC, Annville, PA, US
- Lab TO Pharmacy, LLC, Annville, PA, US
- Lab TO Pharmacy, LLC, Annville, PA, US
Prosecution history
- 13 Dec 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Dec 2022 — REGISTERED-PRINCIPAL REGISTER
- 10 Nov 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Nov 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Nov 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Jul 2022 — USE AMENDMENT FILED
- 03 Nov 2022 — DIVISIONAL PROCESSING COMPLETE
- 07 Jul 2022 — DIVISIONAL REQUEST RECEIVED
- 25 Oct 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Aug 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Jul 2022 — TEAS STATEMENT OF USE RECEIVED
- 07 Jul 2022 — TEAS REQUEST TO DIVIDE RECEIVED
- 08 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jan 2022 — SOU EXTENSION 3 GRANTED
- 06 Jan 2022 — SOU EXTENSION 3 FILED